GALEAS® Bladder — Home Bladder Cancer Test
£699.00
£549.00
Detect bladder cancer markers from a simple urine sample at home. Clinical-grade molecular testing, originally developed for use in NHS pathways.
Trust Badges Row
- ✓ Free UK Shipping
- ✓ Results in 10–14 Days
- ✓ Simple Urine Sample
- ✓ NHS-Pathway Technology
Haematuria-I confirm I have visible or non visible blood in my urine & no previous cancer diagnosis
I confirm no urinary tract infection
Key Features
Main Product Description
What GALEAS® Bladder Detects
GALEAS Bladder is an advanced urine test that detects molecular markers associated with bladder cancer. Unlike basic dipstick tests, it analyses specific genetic and protein markers that indicate the presence of bladder tumour cells — including non-visible (microscopic) changes that wouldn't be caught by visual inspection.
Who Should Take This Test
- Anyone with blood in their urine (visible or detected on a test)
- Smokers and ex-smokers (smoking is a leading bladder cancer risk factor)
- People with occupational exposure to dyes, rubber, or industrial chemicals
- Anyone over 50 wanting routine peace of mind
- People previously treated for bladder cancer monitoring recurrence (alongside their specialist's plan, not as a replacement)
Important Note
Visible blood in urine (haematuria) should always be discussed with your GP urgently, regardless of any home test result. GALEAS is a screening tool, not a substitute for medical assessment.
How It Works
1. Order & Receive
Free UK delivery within 2 working days. Urine collection kit included.
2. Provide Your Sample
Collect a urine sample at home using the included container. Takes 1 minute.
3. Receive Your Results
Lab-verified molecular analysis report in your secure account within 10–14 days.
Product FAQ
Is GALEAS a replacement for a cystoscopy?
No. Cystoscopy remains the gold standard for diagnosing bladder cancer. GALEAS is a screening and triage tool — if positive, your GP will likely refer you for further investigation.
What does a positive result mean?
It means molecular markers associated with bladder cancer were detected and further investigation is recommended. It does not confirm cancer — only further tests can do that.
Can I take this if I have a UTI?
We recommend waiting until any urinary tract infection has been fully treated before testing, as infections can affect results.
Is this the same test used by the NHS?
GALEAS technology has been evaluated in NHS clinical pathways. The exact protocols and use cases differ between home use and clinical settings.
Biomarkers checked
Genes tested:
AKT1, ERBB2, NRAS,BRAF, ERBB3 ,PIK3CA
C3orf70, ERCC2, RHOB
CDKN1A, FBXW7, RXRA
CDKN2A, FGFR3, SF3B1
CREBBP, HRAS, TERT (promoter)
CTNNB1, KDM6A, TP53
ELF3, KRAS
Further information regarding these genes can be found here
Biomarkers were identified by Prof Rik Bryan and Dr Doug Ward at Birmingham
University, UK.
• NGS sequencing panel that targets promoter and exonic regions of 23 of the
most relevant genes associated with bladder cancer
• Identified by a combination of publicly available data and deep exome
sequencing
• Exome studies were performed on Caucasian populations
• 451 somatic mutations present in the panel have been shown to detect 96%
of bladder cancers in over 644 clinical samples.